148 related articles for article (PubMed ID: 37946117)
1. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
[TBL] [Abstract][Full Text] [Related]
2. Exploring assessment of balance using virtual reality in patients at risk of chemotherapy-induced peripheral neuropathy.
Teng C; Chiarovano E; Tighe D; Bui KT; Venkatesha ; Blinman PL; MacDougall HG; Vardy JL
Intern Med J; 2023 Aug; 53(8):1356-1365. PubMed ID: 35762188
[TBL] [Abstract][Full Text] [Related]
3. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
[TBL] [Abstract][Full Text] [Related]
4. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
[TBL] [Abstract][Full Text] [Related]
5. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Lin KY; Chen PS; Lin CF
BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
[TBL] [Abstract][Full Text] [Related]
6. Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB
Asia Pac J Clin Oncol; 2023 Feb; 19(1):243-249. PubMed ID: 35879821
[TBL] [Abstract][Full Text] [Related]
7. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
[TBL] [Abstract][Full Text] [Related]
8. Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity.
Mahfouz FM; Li T; Joda M; Harrison M; Kumar S; Horvath LG; Grimison P; King T; Goldstein D; Park SB
J Neurol Sci; 2024 Feb; 457():122862. PubMed ID: 38185015
[TBL] [Abstract][Full Text] [Related]
9. Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN).
Stoller S; Capozza S; Alberti P; Lustberg M; Kleckner IR
Support Care Cancer; 2023 Apr; 31(5):293. PubMed ID: 37086308
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.
Tanay MAL; Armes J; Moss-Morris R; Rafferty AM; Robert G
J Cancer Surviv; 2023 Feb; 17(1):254-277. PubMed ID: 33710510
[TBL] [Abstract][Full Text] [Related]
11. Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Cao A; Cartmel B; Li FY; Gottlieb LT; Harrigan M; Ligibel JA; Gogoi R; Schwartz PE; Esserman DA; Irwin ML; Ferrucci LM
JAMA Netw Open; 2023 Aug; 6(8):e2326463. PubMed ID: 37526937
[TBL] [Abstract][Full Text] [Related]
12. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
[TBL] [Abstract][Full Text] [Related]
13. Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes.
Mahfouz FM; Li T; Joda M; Harrison M; Horvath LG; Grimison P; King T; Marx G; Goldstein D; Park SB
Support Care Cancer; 2023 Dec; 32(1):46. PubMed ID: 38117349
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
Misawa S; Denda T; Kodama S; Suzuki T; Naito Y; Kogawa T; Takada M; Suichi T; Shiosakai K; Kuwabara S;
BMC Cancer; 2023 Nov; 23(1):1098. PubMed ID: 37951905
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
[TBL] [Abstract][Full Text] [Related]
16. Neurological Outcomes of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer: A Systematic Review and Meta-Analysis.
Suzuki K; Morishita S; Nakano J; Okayama T; Inoue J; Tanaka T; Fukushima T
Integr Cancer Ther; 2023; 22():15347354231185110. PubMed ID: 37822238
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced peripheral neuropathy: A current review.
Staff NP; Grisold A; Grisold W; Windebank AJ
Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB
J Natl Compr Canc Netw; 2023 Feb; 21(2):125-132.e3. PubMed ID: 36791763
[TBL] [Abstract][Full Text] [Related]
19. Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy.
Hertz DL; Tofthagen C; Rossi E; Bernasconi DP; Lim J; Carlson M; Sheffield KE; Nekhlyudov L; Grech L; Von Ah D; Mayo SJ; Ruddy KJ; Chan A; Alberti P; Lustberg MB; Tanay M
Support Care Cancer; 2023 Dec; 32(1):48. PubMed ID: 38129602
[TBL] [Abstract][Full Text] [Related]
20. Lagged Relationships Among Chemotherapy-Induced Peripheral Neuropathy, Sleep Quality, and Physical Activity During and After Chemotherapy.
Bulls HW; Hoogland AI; Small BJ; Kennedy B; James BW; Arboleda BL; Shahzad MMK; Gonzalez BD; Jim HSL
Ann Behav Med; 2021 Aug; 55(9):844-852. PubMed ID: 33196081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
